Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement
Condition: CNS Lymphoma Interventions: Drug: Orelabrutinib; Drug: Rituximab; Drug: Chemotherapy Sponsor: Ruijin Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials